NASDAQ · STOCK
Haemonetics
$85.61
52W $47.32 – $87.32
47/100
$3.89B
41.9
0.52
Is HAE Bullish or Bearish?
Mixed.
Innellis AI committee rates Haemonetics (HAE) Watch with a composite score of 47/100
, based on 7 analysts with 71% agreement.
Last updated July 31, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +13.28 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -6.72 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee sees neither a compelling opportunity nor a clear risk at this stage. Conditions remain neutral — patience is warranted.
Bull & Bear Case
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 39.2 is moderate-to-rich — Value
- Debt-to-equity of 1.54 adds balance-sheet risk to the value case — Value
- Revenue declining -2.0% YoY -- this is not a growth story right now — Growth
- EPS declining -38.7% YoY despite any revenue growth — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- RSI at 80 is in overbought territory — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 31, 2026
Overall Committee Score
47/100
Agreement
71%
Analysts
7
Conviction
Moderate
Sector Rank
Top 100%
of 93 Healthcare peers
Value Analyst
neutral
43
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 39.2 is moderate-to-rich
Growth Analyst
bearish
38
/ 100 · High confidence
Growth story is weak, decelerating, or inconsistent
+ 4 consecutive earnings beats -- consistent execution
− Revenue declining -2.0% YoY -- this is not a growth story right now
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− RSI at 80 is in overbought territory
Risk Analyst
bearish
32
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 1.54) amplifies downside in a stress scenario
Macro Analyst
neutral
58
/ 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
53
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Investment Thesis Evolution
Committee score moved marginally from 47.4 to 46.7.
- Conviction changed from contested to moderate.
- Committee agreement increased notably from 57% to 71%.
- New bearish signals: 5 appeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 4 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
- Risk Analyst: +1 bearish signal(s).
- Technical Analyst: +1 bearish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-07-30 to 2026-07-31 (1 day apart).
Technical Analysis
RSI (14)
81.7
Overbought
MACD Histogram
0.649
Bullish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Hh Hl
Support
$84.46
Resistance
$86.50
Bollinger %B
1.00
Inside Bands
Price vs Moving Averages
EMA 9
$82.08
Above
EMA 21
$79.18
Above
EMA 50
$74.54
Above
EMA 200
$68.22
Above
Fundamental Analysis
Valuation
49
Growth
73
Profitability
0
Financial Health
74
Cash Flow
37
Valuation
P/E Ratio
41.9×
P/B Ratio
4.97×
PEG Ratio
-1.08
Dividend Yield
0.00%
52W High
$87.32
52W Low
$47.32
Quality & Growth
ROE
12.2%
ROA
4.1%
Gross Margin
57.3%
Operating Margin
18.1%
Revenue Growth YoY
—
Debt / Equity
1.54
AI Fundamental Assessment
P/E ratio of 41.9 (rich relative to a 15-40x range); Price-to-book of 5.0x; PEG ratio of -1.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.1%; Return on assets of 0.0%; Net margin of 0.1%; Gross margin of 0.6%; Current ratio of 2.95 (healthy short-term liquidity); Debt-to-equity of 1.54; Free cash flow margin of 0.9% (thin cash generation); Free cash flow per share is positive (5.63); Most recent quarter beat estimates by 0.4%; 4 consecutive earnings beats; EPS growth decelerating (+3.1% -> -1.5% QoQ); Analyst estimates rising over recent quarters
Get the Full HAE Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →